Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes.

Phumipamorn S, Pongwecharak J, Soorapan S, Pattharachayakul S.

Prim Care Diabetes. 2008 Feb;2(1):31-7. doi: 10.1016/j.pcd.2007.12.001.

PMID:
18684418
2.

Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.

Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, Giri M.

J Clin Pharm Ther. 2011 Oct;36(5):602-13. doi: 10.1111/j.1365-2710.2010.01218.x.

PMID:
21143256
4.

Effect of a 36-month pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients.

Neto PR, Marusic S, de Lyra Júnior DP, Pilger D, Cruciol-Souza JM, Gaeti WP, Cuman RK.

J Pharm Pharm Sci. 2011;14(2):249-63.

6.

Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility.

Wallgren S, Berry-Cabán CS, Bowers L.

Ann Pharmacother. 2012 Mar;46(3):353-7. doi: 10.1345/aph.1Q564.

PMID:
22395249
7.

A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes.

Chan CW, Siu SC, Wong CK, Lee VW.

J Cardiovasc Pharmacol Ther. 2012 Mar;17(1):57-64. doi: 10.1177/1074248410396216.

PMID:
21335480
8.

Community pharmacist-provided extended diabetes care.

Doucette WR, Witry MJ, Farris KB, McDonough RP.

Ann Pharmacother. 2009 May;43(5):882-9. doi: 10.1345/aph.1L605.

PMID:
19401477
9.

Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus.

McFarland M, Davis K, Wallace J, Wan J, Cassidy R, Morgan T, Venugopal D.

Pharmacotherapy. 2012 May;32(5):420-6. doi: 10.1002/j.1875-9114.2011.01038.x.

PMID:
22488512
10.
11.
13.

Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy.

Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart K, Krum H.

J Clin Pharm Ther. 2004 Feb;29(1):23-30.

PMID:
14748894
14.

Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia.

Lim PC, Lim K, Embee ZC, Hassali MA, Thiagarajan A, Khan TM.

Pak J Pharm Sci. 2016 Mar;29(2):595-601.

PMID:
27087103
15.

Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.

Farmer AJ, Wade AN, French DP, Simon J, Yudkin P, Gray A, Craven A, Goyder L, Holman RR, Mant D, Kinmonth AL, Neil HA; DiGEM Trial Group..

Health Technol Assess. 2009 Feb;13(15):iii-iv, ix-xi, 1-50. doi: 10.3310/hta13150.

16.

Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes.

Cohen LB, Taveira TH, Khatana SA, Dooley AG, Pirraglia PA, Wu WC.

Diabetes Educ. 2011 Nov-Dec;37(6):801-12. doi: 10.1177/0145721711423980.

PMID:
22021025
17.
18.

[Effectiveness of PRECEDE model for health education in metabolic control and reduction of cardiovascular risk factors in patients with diabetes type 2].

Salinero-Fort MA, Arrieta-Blanco F, Carrillo-de Santa Pau E, Martín-Madrazo C, Piñera-Tames M, Vázquez-Martínez C, Abánades-Herranz JC.

Rev Clin Esp. 2009 Jul-Aug;209(7):325-31. Spanish. Erratum in: Rev Clin Esp. 2009 Oct;209(9):423. Salinero-Fort M [corrected to Salinero-Fort, M A].

PMID:
19709535
19.

Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults.

Taveira TH, Dooley AG, Cohen LB, Khatana SA, Wu WC.

Ann Pharmacother. 2011 Nov;45(11):1346-55. doi: 10.1345/aph.1Q212.

PMID:
22028418
20.
Items per page

Supplemental Content

Support Center